Safety, Bleeding & Monitoring

Good hormone care depends on safety, bleeding review, and follow-up

WHI provides doctor-led online care for adult women, with structured review of treatment suitability, bleeding patterns, symptom response, and red flags that may need investigation or urgent in-person care.

This page explains how WHI approaches safety in menopause and hormone care.

It covers what is routinely monitored, why bleeding matters, when urgent review is needed, and how follow-up works after treatment starts or changes.

Why safety and monitoring matter

Not every woman with midlife symptoms needs the same treatment, and good care does not stop at prescribing.

WHI uses structured follow-up to review symptom response, bleeding pattern, tolerability, safety, and whether the plan still fits the wider clinical picture.

Bleeding matters

Bleeding is one of the most important safety signals in menopause and hormone care.

In perimenopause, bleeding may become more erratic, but persistent heavy bleeding or intermenstrual bleeding still needs proper review.

In postmenopause, any bleeding is abnormal until properly assessed.

Progesterone and endometrial protection

If a woman has a uterus and uses systemic estrogen, endometrial protection is usually needed.

That is why progesterone or another suitable progestogen plan matters.

This is a central safety issue in hormone prescribing.

What WHI routinely reviews

symptom response
bleeding pattern and any change from baseline
side effects and tolerability
route and dose suitability
uterus status and endometrial protection plan
blood pressure and cardiovascular context where relevant
migraine, clotting, breast, liver, or metabolic factors where relevant
whether local treatment, systemic treatment, non-hormonal care, or onward referral is the next step

When follow-up usually happens

Usually around 8 weeks after starting or changing treatment. The aim is to review symptom change, bleeding pattern, and whether the route or dose needs adjustment.
Stable patients still need periodic every 6 months.
Treatment may be continued, changed, reduced, paused, or redirected depending on progress, side effects, red flags, and the wider clinical picture.

What bleeding on HRT may mean

Bleeding after starting or changing hormone therapy is not all interpreted in the same way.

Some patterns may settle, while persistent unscheduled bleeding needs review.

WHI looks at timing, treatment type, uterus status, and whether further assessment is needed.

Postmenopausal bleeding should never be brushed aside.

Persistent heavy bleeding or recurrent bleeding between periods also needs proper review.

Red flags that need urgent assessment

Seek urgent local medical review if there is:

new heavy bleeding
postmenopausal bleeding with concerning symptoms
calf pain or unilateral leg swelling
chest pain or severe shortness of breath
new neurological deficits or stroke-like symptoms
severe headache that is new or worrying
jaundice or severe right upper abdominal pain
sudden significant deterioration or acute deterioration in general condition